Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Clinical trial NCT01210482 · COMPLETED

Trial details

NCT number: NCT01210482
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Carcinoma

Start date: 2010-08-24
Primary completion: 2018-03-30
Enrollment: 1050

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.